Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sonoma Pharmaceuticals In...

    NASDAQ: SNOA · Real-Time Price · USD
    3.32
    -0.05 (-1.48%)
    At close: Jun 06, 2025, 3:59 PM
    3.32
    0.00%
    After-hours: Jun 06, 2025, 04:04 PM EDT

    Sonoma Pharmaceuticals Statistics

    Share Statistics

    Sonoma Pharmaceuticals has 1.62M shares outstanding. The number of shares has increased by -91.5% in one year.

    Shares Outstanding

    n/a
    		 1.62M

    Shares Change (YoY)

    n/a
    		 -91.5%

    Shares Change (QoQ)

    n/a
    		 20.65%

    Owned by Institutions (%)

    n/a
    		 2.79%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 3,105

    FTD / Avg. Volume

    n/a
    		 0.12%

    Short Selling Information

    The latest short interest is 42.7K, so 2.64% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 42.7K

    Short % of Shares Out

    n/a
    		 2.64%

    Short % of Float

    n/a
    		 2.68%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.58 and the forward PE ratio is -1.85. Sonoma Pharmaceuticals's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.58

    Forward PE

    n/a
    		 -1.85

    PS Ratio

    n/a
    		 0.22

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 0.45

    P/FCF Ratio

    n/a
    		 -1.15

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Sonoma Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.37, with a Debt / Equity ratio of 0.1.

    Current Ratio

    n/a
    		 3.37

    Quick Ratio

    n/a
    		 2.64

    Debt / Equity

    n/a
    		 0.1

    Debt / EBITDA

    n/a
    		 -0.13

    Debt / FCF

    n/a
    		 -0.25

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,273,500

    Profits Per Employee

    n/a
    		 $-483,500

    Employee Count

    n/a
    		 10

    Asset Turnover

    n/a
    		 0.86

    Inventory Turnover

    n/a
    		 2.94

    Taxes

    Income Tax

    n/a
    		 -196K

    Effective Tax Rate

    n/a
    		 3.9%

    Stock Price Statistics

    The stock price has increased by -19.02% in the last 52 weeks. The beta is 1.4, so Sonoma Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.4

    52-Week Price Change

    n/a
    		 -19.02%

    50-Day Moving Average

    n/a
    		 2.99

    200-Day Moving Average

    n/a
    		 2.95

    Relative Strength Index (RSI)

    n/a
    		 52.15

    Average Volume (20 Days)

    n/a
    		 2,633,074

    Income Statement

    In the last 12 months, Sonoma Pharmaceuticals had revenue of 12.73M and earned -4.83M in profits. Earnings per share was -5.32.

    Revenue

    n/a
    		 12.73M

    Gross Profit

    n/a
    		 4.75M

    Operating Income

    n/a
    		 -4.7M

    Net Income

    n/a
    		 -4.83M

    EBITDA

    n/a
    		 -4.53M

    EBIT

    n/a
    		 -4.7M

    Earnings Per Share (EPS)

    n/a
    		 -5.32
    Full Income Statement

    Balance Sheet

    The company has 3.13M in cash and 608K in debt, giving a net cash position of 2.52M.

    Cash & Cash Equivalents

    n/a
    		 3.13M

    Total Debt

    n/a
    		 608K

    Net Cash

    n/a
    		 2.52M

    Retained Earnings

    n/a
    		 -194.35M

    Total Assets

    n/a
    		 13.67M

    Working Capital

    n/a
    		 8.68M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -2.4M and capital expenditures -17K, giving a free cash flow of -2.42M.

    Operating Cash Flow

    n/a
    		 -2.4M

    Capital Expenditures

    n/a
    		 -17K

    Free Cash Flow

    n/a
    		 -2.42M

    FCF Per Share

    n/a
    		 -2.66
    Full Cash Flow Statement

    Margins

    Gross margin is 37.26%, with operating and profit margins of -36.91% and -37.97%.

    Gross Margin

    n/a
    		 37.26%

    Operating Margin

    n/a
    		 -36.91%

    Pretax Margin

    n/a
    		 -39.51%

    Profit Margin

    n/a
    		 -37.97%

    EBITDA Margin

    n/a
    		 -35.53%

    EBIT Margin

    n/a
    		 -36.91%

    FCF Margin

    n/a
    		 -18.96%

    Dividends & Yields

    SNOA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for SNOA.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 30, 2024. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Aug 30, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -19.1

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist